Please try another search
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
Name | Age | Since | Title |
---|---|---|---|
John P. McDonough | 64 | 2021 | Independent Chairman of the Board |
Hilde Rh De Geus | - | 2014 | Member of Scientific Advisory Board |
Jean-Louis Vincent | - | 2014 | Chairman of the Scientific Advisory Board |
Andrew Lewington | - | 2014 | Vice Chairman of Scientific Advisory Board |
Michael Scott Singer | 51 | 2019 | Independent Director |
Michael Haase | - | 2014 | Member of Scientific Advisory Board |
Donnie M. Hardison | 74 | 2021 | Independent Vice Chairman of the Board |
Ninfa M. Saunders | 65 | 2023 | Independent Director |
Laurent Jacob | - | 2014 | Member of Scientific Advisory Board |
Claudio Ronco | - | 2014 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review